Full-Time
Value Stream Planner
Smith+Nephew
10,001+ employees
Global medical devices for orthopedics
No salary listed
Withernsea, UK
Hybrid
 Operations & Logistics (2) |
|---|
| , |
- A degree in business or logistics, or equivalent experience in a similar role
- Strong skills in Excel and SAP, with knowledge of ERP/MRP systems
- An understanding of supply chain processes and how planning impacts operations
- Awareness of supply chain end to end systems and processes and impact of Planning on other areas and the bigger picture (financial and operational targets)
- A problem-solving mindset and the ability to adapt to changing priorities
- Awareness of ABC Planning techniques
- Liaise with Manufacturing, Materials planners and Supply Planning Managers as required to ensure achievement of manufacturing plans including responding to material shortages. Key interface with these Depts including QA.
- To monitor and ensure effective flow into the manufacturing line side, movement of materials and removal of returns and waste streams.
- Liaise with manufacturing and Material Planners over schedule changes and prioritization.
- Liaise with Material Planners on material introduction and run outs.
- Provide accurate feedback to Supply Planning Managers on completion of plans against weekly schedules.
- Participate in projects to improve short- and long-term planning and scheduling processes and ways of working.
- Support new product launches, working closely with Supply Planning Managers, Materials Planning, Technical, MDM and QA
- Refine systems, methods and processes to allow Value Streams to better anticipate Supply challenges and minimize cost/disruption.
- Support Proactive forward planning to develop the long term SIOP process and visibility of capacity, inventory and material challenges.
- Collaboration with Value streams to support capacity reviews and Factory Order Fulfilment data for fixed cycle and longer term.
- Support/Develop cost/service KPI's as required by the business.
- Support reviews and recommendations of changes to master data that impact OEE/Efficiency/Recoveries etc.
- Work closely with factory operatives on Plan execution, including regular presence on shop floor, including the Tier meetings.
Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.
Company Size
10,001+
Company Stage
IPO
Headquarters
Watford, United Kingdom
Founded
1856
Simplify's Take
What believers are saying
- Innovation drove over 60% of 2025 growth; products launched past five years deliver double-digit growth.
- Free cash flow surged 52.5% to $840M, enabling $500M share buyback and strategic acquisitions.
- Integrity Orthopaedics acquisition expands $875M rotator cuff repair market with proven clinical outcomes.
What critics are saying
- Memphis manufacturing consolidation creates single-point-of-failure for orthopedics production in 12-24 months.
- Integrity acquisition's $225M performance milestones depend on unproven Tendon Seam technology achieving adoption.
- Chinese pricing reforms and US reimbursement headwinds compress margins simultaneously in 2026.
What makes Smith+Nephew unique
- Tendon Seam rotator cuff technology addresses 500,000 annual US procedures with lower re-tear rates.
- ALLEVYN COMPLETE CARE releases 100 times fewer bacteria than competing foam dressings.
- RENASYS EDGE achieves 88% patient compliance with lightweight, modular negative pressure system.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Smith+Nephew who can refer or advise you
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Holidays
Flexible Work Hours
Parental Leave
Fertility Treatment Support
Family Planning Benefits
Tuition Reimbursement
Wellness Program
Mental Health Support
Volunteer Time Off
Home Office Stipend
Phone/Internet Stipend
Discounted Stock Options
Health Savings Account/Flexible Spending Account
Employee Assistance Program
PTO/vacation?
Paid Sick Leave
Company News
Smith & Nephew reported strong full-year 2025 results, with revenue of $6.2 billion representing 5.3% underlying growth and 6.1% reported growth. Fourth-quarter revenue reached $1.7 billion, growing 6.2% on an underlying basis. The medical device company achieved 160 basis points of margin expansion, with trading profit of $1.2 billion and adjusted earnings per share of $1.02, up 21%. Free cash flow increased 52.5% year-on-year to $840 million, enabling completion of a $500 million share buyback programme. Innovation drove over 60% of growth, with products launched in the past five years delivering double-digit growth across all business units. For 2026, the company expects 6% organic revenue growth and 8% trading profit growth to around $1.3 billion, though it faces headwinds from Chinese pricing reforms and US reimbursement changes.
Smith+Nephew has signed an exclusive US distribution agreement with RMR Ortho to add the A'TOMIC Nitinol Fixation System to its Trauma, Foot & Ankle and Hand & Wrist portfolio. The partnership enables Smith+Nephew to expand its participation in high-frequency fracture and arthrodesis procedures whilst utilising its existing Extremities and Trauma sales channel. The dynamic compression fixation solution complements the company's current technologies. Scott Gunn, Vice President of US Marketing at Smith+Nephew, said the collaboration reflects the company's disciplined approach to portfolio expansion and continued focus on driving sustainable growth.
Smith+Nephew has acquired Integrity Orthopaedics for an initial $225 million cash payment, plus up to $225 million in performance-based payments over five years. The deal strengthens Smith+Nephew's sports medicine portfolio with the Tendon Seam rotator cuff repair technology. Founded in 2020, Integrity Orthopaedics developed the innovative system to address high failure rates in traditional rotator cuff repairs. The technology uses patented micro-anchors and continuous suture designed to deliver stronger repairs and lower re-tear rates. Early clinical results show reduced pain and shorter recovery times. The rotator cuff repair market performs approximately 500,000 procedures annually in the US, valued at $875 million. The acquisition, expected to close by end of January 2026, will be financed from existing cash facilities and is expected to be accretive to trading profit margin by 2028.
Download the Swiss reference publication on investments, investors and exits in our assets section.
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for robotics, knees, hips, and shoulders at AAOS 2025.